Of 151 patients with a possible anaphylactoid/anaphylactic reaction to a muscle relaxant investigated over a 20-year period, follow-up for any subsequent general anaesthesia was complete in 145 (96%). One hundred and twenty-two anaesthetics in 72 patients were documented. There were no anaesthetic-related deaths. No subsequent reactions were seen if muscle relaxants were not used in the subsequent anaesthetic, nor were they in patients with severe reactions if the original intradermal test had been equivocal or negative. In the patients with a severe reaction and a positive intradermal test to one or more muscle relaxants, six out of 40 later anaesthetics using muscle relaxants were associated with clinical problems, three being probable anaphylactic reactions, whilst three were minor. Intradermal testing should be performed prior to surgery in this group of patients for the muscle relaxant(s) planned, or an anaesthetic technique which avoids relaxants should be used. This review should encourage other centres to undertake similar follow-up.
The incidence of anaphylactoid/anaphylactic reactions appears to have increased over recent decades, though this may be due to improved reporting and assessment. The reported incidence varies from 1:1750 1 to 1:20,000 2 . Muscle relaxants are the cause of 60 to 75% of these reactions [1] [2] [3] . The diagnosis of an anaphylactoid reaction depends on a positive clinical history in the absence of a positive skin test or of a raised specific IgE radioimmune assay, whereas for an anaphylactic reaction there should be a positive clinical history, and a positive skin test combined with a specific raised IgE radioimmune assay or, more recently, an elevated serum tryptase [1] [2] [3] [4] . In practice, clear categorization of a reaction may sometimes prove difficult.
Since 1974, Canterbury and West Coast patients who have had a suspected anaphylactic reaction have been referred to a skin testing clinic run by anaesthetists at Christchurch Hospital with the support of the Immunology Department. A protocol has evolved for the referral and assessment of these patients, which is used by five centres in New Zealand 5 . We have at various times performed serum IgE, complement, and for a while, histamine assays. From 1992 blood samples have been sent to Auckland for serum tryptase levels and to Sydney for radioimmunoassay of specific IgE.
There is little information regarding the risks of subsequent general anaesthesia for patients who have suffered an anaphylactoid/anaphylactic reaction 6, 7 . For this reason one of us (MAT) set out to follow up referred patients who had received a muscle relaxant as part of their index anaesthetic.
PATIENTS AND METHODS
One hundred and fifty-one patients were studied, who had been referred between 1974 and 1995 following a moderate to severe clinical reaction to general anaesthesia in which a muscle relaxant was used. There were 123 women and 28 men, with the largest number of patients in the 20 to 40 year age group. Reactions were classified as either moderate or severe in the same manner as in previous epidemiological studies 1 .
At assessment a detailed medical, surgical and allergy history was taken and intradermal testing conducted for the drugs used. Intradermal tests were performed according to Fisher 5 on the skin of the back 8 and scored as: -Positive: a wheal 8 mm or more, and a flare persisting for more than 20 minutes, with a negative control. -Equivocal: a flare persisting for more than 20 minutes with a negative control, or a positive test to a different muscle relaxant from the one used. -Negative: no skin sensitivity observed.
The diagnosis of an anaphylactic reaction in this series was based on the clinical history and a positive skin test alone, since over the twenty-year period the biochemical tests and immunoassays employed have varied and evolved based on expert opinion and local laboratory capabilities.
In 1996, a questionnaire was sent to each patient, asking if they had had a subsequent general anaesthetic. If they had, they were asked to report whether or not there had been a problem. Written consent was obtained to review each patient's medical records. For those who did not reply, the electoral roll was searched for a change of address and the questionnaire was sent out again. For those who then did not reply, medical records were searched for the next of kin and the patient's family practitioner approached for contact details. For patients who had died, their case notes were searched for the cause of death. The data were analysed to identify those patients who had undergone subsequent general anaesthesia and the drugs used, especially muscle relaxants. Details of any clinical problems that had occurred with subsequent anaesthesia were obtained from the patient's medical records.
RESULTS
One hundred and forty-five of the 151 patients (96%) were successfully contacted. Table 1 gives the results of the survey. Seventy-two patients underwent 122 subsequent general anaesthetics. Fifty of these patients had had a severe reaction and 22 a moderate reaction to their index anaesthetic. Twenty-seven patients had more than one subsequent general anaesthetic. Seventy-three patients of whom 12 had died had not had another anaesthetic. There were no anaesthetic-related deaths.
In Table 2 the result of the intradermal test is compared with the severity of the clinical reaction in the 72 patients undergoing a subsequent general anaesthetic. A positive skin test was present in 70% of patients with severe reactions but only in 18% of those with moderate reactions.
There were 35 subsequent anaesthetics in the group who had had a moderate reaction. In 23 of these a muscle relaxant different from that in the index anaesthetic was used. There was only one minor clinical problem in this group-mild bronchospasm on induction in a heavy smoker.
The 50 patients who had had a severe reaction underwent 87 subsequent anaesthetics. In 53 of these a muscle relaxant was used ( Table 3) . Clinical problems arose during six of these procedures, all in patients with a previously positive intradermal test (Table 3 ). In 49 procedures a muscle relaxant different from the index anaesthetic was used. In the other four cases, the intradermal test had been negative or equivocal at the original assessment and the same relaxant was used in the subsequent procedure without incident. In the severe reaction/positive skin test group, three of the six subsequent clinical reactions were minor (coughing on induction and/or mild bronchospasm) and occurred in patients with a history of smoking and/or asthma. None of these patients suffered hypotension and none underwent further intradermal testing.
The other three were suspected anaphylactic reactions occurring in two patients. Case 1 was a healthy 39-year-old woman with no known history of allergy, whose index intradermal test had been positive to suxamethonium. Her first subsequent anaesthetic 14 years later consisted of triazolam, pethidine and ranitidine premedication, followed by a gaseous induction with N 2 O:O 2 :halothane and pancuronium. She developed severe urticaria and facial oedema. Intradermal testing was positive for pethidine, suxamethonium, vecuronium and alcuronium, and equivocal to pancuronium and thiopentone. Two further total intravenous anaesthetics with alfentanyl and propofol and no muscle relaxants were both uneventful.
Case 2 was a healthy 21-year-old woman whose index intradermal test was positive for alcuronium. Five years later, she received premedication consisting of omnopon, prochlorperazine and sodium citrate, and induction with thiopentone and vecuronium. She coughed excessively at induction and rapidly developed severe bronchospasm. However, this was not recognized as a drug reaction at the time. One year later she received triazolam and hydrocortisone premedication, followed by fentanyl, midazolam and atracurium without problems. The next year she received triazolam premedication and fentanyl, propofol and vecuronium. She coughed at induction, developed severe facial oedema and her oxygen saturation fell to 60%. Intradermal testing was positive for suxamethonium and vecuronium, but negative to atracurium.
DISCUSSION
Defining an anaphylactoid/anaphylactic reaction remains a problem as the clinical symptoms are the same whether the mechanism of the reaction is IgE mediated, or a direct non-immune idiosyncratic mediator release or, as has been described for induction agents but not muscle relaxants, mediator (histamine) release by activation of the complement system via an alternative pathway 9 . Baldo and Fisher first demonstrated IgE antibodies to muscle relaxants 10 whilst more recently, more sensitive radioimmunoassays have been developed 11 . However, the presence of IgE antibodies to the allergic determinants does not appear sufficient on its own to induce allergic reactions 12 .
Both the intradermal test and the prick test have a reported sensitivity of 97% for neuromuscular blockers 8 . Correlation between the intradermal test and radioimmunoassay does vary 13 , but improves as the sensitivity of the radioimmunoassay increases 14 .
More importantly the persistence of a positive intradermal test for many years makes it a very valuable test prior to a subsequent anaesthetic 15 . In a small proportion of patients however, the intradermal test may change with time, becoming positive to drugs to which they were previously negative and vice versa 16 . Despite this, the intradermal test remains the most useful clinical screening test at this time.
The above discussion is relevant to the group of patients we studied because the diagnosis was made from the clinical history and the result of the intradermal tests alone. Serum tryptase assays which were not always available to us could have helped in the diagnosis in the group who had a moderate reaction, or those in the severe reaction group who had an equivocal or negative intradermal test, by indicating whether or not any histamine release from mast cells had occurred 4 . However, in those patients with severe clinical reactions and positive intradermal tests there is little doubt about the diagnosis of an anaphylactic reaction.
There is very little information in the literature regarding the risks of subsequent exposure of patients who have had a previous anaphylactoid/anaphylactic reaction during general anaesthesia 6, 7 . It has been presumed that these patients may be at increased risk of subsequent reactions and certainly there is evidence of cross-sensitivity between different muscle relaxants 17 .
The only follow-up similar to the present series is a French study of 261 (74.6%) of 350 patients who had undergone intradermal testing in the mid-1980s 7 . Seventy-eight patients (30% of the 261 patients) had another general anaesthetic, but information was available for only 51 of these. Twenty-four had a negative prick test and 27 a positive test following the index anaesthetic. Of these 27, 13 underwent 19 subsequent anaesthetics in which a muscle relaxant (different from the index anaesthetic) was used. In three of these patients the anaesthetist was not aware of the results of the previous prick test. No new suspected anaphylactic reactions were observed in this survey and none of the patients underwent repeat skin testing.
In our study, follow-up was completed in 96% of Although in epidemiological terms this is a small series, it nevertheless allows for some clinical implications to be drawn and should encourage other centres to undertake similar follow-up. No subsequent anaphylactoid/anaphylactic reactions were seen in patients in whom muscle relaxants were not used subsequently, nor in patients with previous moderate reactions in whom a different muscle relaxant was used. In addition, in patients who had severe reactions, if the original intradermal test was equivocal or negative, then the subsequent use of a muscle relaxant was not associated with problems.
In patients who had had a severe reaction and a positive skin test, six out of 40 new anaesthetics were associated with clinical problems, three of these in two patients being probable anaphylactic reactions. Although most patients had a successful outcome to their subsequent anaesthetic, the fact that three serious reactions (7.5%) occurred in this group of patients implies they require careful assessment and management for subsequent anaesthesia.
An anaphylactoid/anaphylactic reaction during anaesthesia is potentially life-threatening. Our data suggest there might be an increased risk of another reaction in those patients with a previous severe clinical reaction and a positive intradermal test to muscle relaxants. As intradermal tests alter with time it would seem prudent in such patients prior to subsequent surgery to perform an intradermal test for all muscle relaxants that previously tested negative or were not tested for 7, 15 . If the intradermal test is unhelpful or equivocal, an IgE radioimmunoassay could supplement the investigation, but not all centres have access to this. Muscle relaxants should be avoided where possible 15 . Documenting the details of anaesthetic reactions and intradermal test results and giving this information to the patient will help in future follow-up and safe clinical management.
